Alan H. Bryce, MD | Authors

Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer

April 19, 2021

ONCOLOGY® editorial board member E. David Crawford, MD, and colleagues, propose a new model for guiding the treatment of prostate cancer that focuses on a “transitional state,” which occurs during the interval of progression to metastatic castration-resistant prostate cancer.